- The Investment Exchange
- Posts
- The Investment Exchange
The Investment Exchange
Issue 116 - Teak Investments in Panama with ECI Developments
Welcome to the latest edition of "The Investment Exchange," your premier source for mergers & acquisitions, investment and personal growth insights. In this issue, we bring you the latest deals and opportunities plus introduce some of the podcasters, influencers and content creators that are shaping the investment landscape.
Weekly Update - Intro
Current Investment Opportunities - Teak Investments in Panama and Nicaragua
Expert Corner - Ascend Is Evolving
Events, Offers, Insights and Announcements - My 10-Day Cortexin Trial
Section 1 - ✉️ This Week’s Update:
This week ended in a hospital bed.
Not exactly where I planned to be but a recurrence from a recent surgery has put a second operation on the table and for a moment, everything slows down whether you like it or not.
But here’s what I’ve learnt…
When you zoom out, it’s all just a tiny blip.
Because while I’ve been forced to pause physically, the machine hasn’t stopped.
Deals are still moving.
Opportunities are still surfacing.
And the momentum we’ve built at Balmoral continues to compound.
In fact, one of the most exciting developments right now sits inside our mobility vertical.
We’re in advanced stages on a bolt-on acquisition that, when completed as expected, positions us for circa 350% growth in just over six months.
Not theoretical growth.
Not “maybe if everything goes right” growth.
Structured, strategic expansion built off the back of an existing platform.
This is exactly how we like to play the game.
Acquire well. Integrate fast. Scale hard.
The biggest opportunities rarely wait for perfect timing.
They reward the people already in motion.
So if you’ve been watching from the sidelines, now’s the moment to lean in.
We still have a small allocation of capital open across current opportunities, but it won’t stay that way for long.
If you’re serious about deploying into high-conviction deals alongside us, reply to this email or message me directly.
Let’s have a conversation.
Section 2 - Investment Opportunity: Teak, Land, and Optionality
Over the past few years, I’ve spent more time looking at real assets in emerging markets.
Not just from an investment perspective.
But from the lens of optionality, residency, and long-term positioning.
One opportunity that continues to come up in conversations is what ECI Development have been building across Panama and Nicaragua.
At its core, it’s simple:
→ Own land
→ Plant teak
→ Let time and biology do the work
But when you look a layer deeper, it becomes more interesting.
These investments combine:
Teak plantations (a globally traded hardwood with long-term demand)
Land ownership in strategic locations
And in many cases, the ability to obtain residency in the country
So you’re not just buying into a single outcome.
You’re building:
Exposure to a real asset
A hedge against currency and market volatility
And a geographic Plan B
Teak itself is a long-term play.
It’s not about quick returns.
It’s about:
Biological growth
Scarcity of quality hardwood
And patience being rewarded over time
What I find particularly interesting is how this fits into a broader strategy:
Most people diversify across stocks, funds and property.
Very few think about diversifying across:
→ Jurisdictions
→ Residency options
→ Real assets outside their home country
That’s where opportunities like this start to stand out.
Live Session with Mike Cobb
To go deeper on this, we’ve got Mike Cobb, Founder & CEO of ECI Development, joining us live.
He’ll be breaking down:
How the teak model works in practice
Why Panama and Nicaragua
The residency pathways linked to these investments
And what investors should actually be looking for
📅 Wednesday 8th
If you’d like access to the session,
DM me “TEAK” and I’ll send you the details because in a world that’s becoming increasingly unpredictable,
having assets, options, and presence in multiple places isn’t a luxury anymore.
It’s strategy.
Section 3 - Expert Corner: Ascend Is Evolving
We’ve been building quietly behind the scenes.
And now it’s time.
Over the coming weeks, we’ll be rolling out the next evolution of Ascend:
The Ascend Method
Ascend Mastermind
The Ascend Partnership
Clearer pathways.
Stronger structure.
Bigger outcomes.
With that… prices are rising.
Not for the sake of it, but because the value, access, and level of execution inside Ascend is moving up significantly.
So if you’ve been sitting on the sidelines…
Watching…
Wondering whether now is the right time to work with me and the team…
Take this as your nudge.
We offer a free initial exploratory call.
No pressure. Just a real conversation about where you are, where you want to go, and whether we can help you get there faster.
Because missing out on the right opportunity is one thing…
But missing out because you didn’t have the right people around you?
That’s almost impossible to quantify.
If you’re even slightly curious, get in touch.
— Ross
Section 4 - Events, Offers, Insights and Announcements: My 10-Day Cortexin Trial
There’s a lot of noise in the “brain optimisation” world right now.
Every week there’s a new supplement, a new stack, a new “breakthrough” promising sharper thinking, better focus, limitless output.
Most of it is average at best.
So I’ve been quietly testing something that sits a little outside the mainstream…
Cortexin.
For those who haven’t come across it, Cortexin is not your typical supplement. It’s a neuroprotective peptide complex derived from animal brain cortex tissue, originally developed and used clinically in Russia.
It’s been around since the late 90s and has been used in medical settings for things like:
Stroke recovery
Traumatic brain injury
Cognitive impairment
So this isn’t some influencer-created nootropic.
It started life as a pharmaceutical intervention.
Mechanistically, it’s interesting.
It crosses the blood-brain barrier and works on multiple pathways… supporting neurotransmitter balance, reducing oxidative stress, and promoting neurotrophic activity (think brain repair and resilience).
That’s the theory.
But what about real-world use?
The Experiment
I ran a 10-day protocol.
No major changes to routine. No stacking it with 10 other compounds. Just Cortexin and observation.
And here’s the honest takeaway…
I’m giving it an 8/10.
Not hype. Not life-changing overnight.
But noticeable.
The biggest signal?
People around me started commenting before I did.
Sharper in conversations.
Faster recall.
More “on it” across the day.
That, for me, is always the real test.
Not what you feel…
What the room feels.
Pharma to Nootropic
What’s interesting is how Cortexin is now making the jump from clinical use into the nootropic world.
That transition is where things get exciting.
Because when something moves:
From hospital → to high performers
…it usually means there’s something there.
That said, this isn’t magic.
It’s a tool.
And like all tools, it depends on the user.
Sleep still matters.
Nutrition still matters.
Environment still matters.
But when those are dialled in, this feels like a genuine edge.
Where I Get Mine
I’ve been using Cosmic Nootropic for years now.
No issues. No drama. Consistent every time.
If you’re curious to try it yourself, they’ve given readers of this newsletter:
10% off everything with code: ALPHA
Final Thought
In a world full of noise…
I’m always looking for signal.
This is one of the few things recently that cut through.
Not perfect.
But very solid.
And in this game, small edges compound fast.
Onwards and upwards 🚀
Have a great day
Ross
P.S These are currently not available in the US
Here are 3 ways we can work together
Apply to join our small group accountability program. With a full 12 months to work together, this could just be what you need to supercharge your business growth, raise investment or get started on the business acquisition ladder.
Submit a pitch deck or investment proposal to share in an upcoming newsletter
Reach out about Joint Venturing, partnering or working with me and the team
You can follow me below
Contact [email protected]
Happy investing!
Ross and The Investment Exchange Team
We hope you find this edition of "The Investment Exchange" informative and valuable. Your feedback and suggestions are important to us, so please feel free to reach out to us with any comments or ideas for future editions.
And remember if you’re an investor, strategic partner or founder exploring an exit, now is a great time to connect. We’ve got exciting projects at Balmoral Partners and Ascend³ from healthcare to high-growth roll-ups and we’re always looking for the right people to join us on the journey.
P.S. Want to explore a fit? Book a quick 20-min call here: https://calendly.com/the_scale_pyramid/30min
Note: This content is intended for informational purposes only and does not constitute financial advice. Please consult with a professional advisor before making any investment de